Hepatitis B Reactivation in People with HIV After Switching to a 2-Drug Anti-HBV Sparing Regimen,
Giulia Morsica(Vita-Salute San Raffaele University), A Castagna(Vita-Salute San Raffaele University), Michela Sampaolo(Vita-Salute San Raffaele University), Sabrina Bagaglio(Vita-Salute San Raffaele University), C Bertoni(Vita-Salute San Raffaele University), Valentina Svicher(University of Rome Tor Vergata), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Nicola Gianotti(Vita-Salute San Raffaele University), Sara Diotallevi(Vita-Salute San Raffaele University), C Muccini(IRCCS Ospedale San Raffaele), Stefano D’ Anna(University of Rome Tor Vergata), Tommaso Clemente(Vita-Salute San Raffaele University), Riccardo Lolatto(IRCCS Ospedale San Raffaele), Romina Salpini(University of Rome Tor Vergata)
Cited by 0
Related Papers
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168
Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy
|Annals of Internal Medicine|2002|136
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133